Moderna Inc (MRNA)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | |
| DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The Days Sales Outstanding (DSO) ratio for Moderna Inc for the years 2020 to 2024 is not available as the values are marked as "— days" for all the years provided. This lack of data regarding DSO makes it challenging to assess the company's efficiency in collecting revenue from its sales within a specific period. A low DSO typically indicates that a company is efficient in collecting receivables, while a high DSO may signal potential issues with sales collection and cash flow management. Without specific DSO numbers, it is not possible to gauge Moderna Inc's effectiveness in managing its accounts receivable turnover.
Peer comparison
Dec 31, 2024